| Bioactivity | m-AM-BBIQ (compound 10) is a dual TLR7 and TLR8 agonist, with EC50 values of 0.12 μM and 1.7 μM for hTLR7 and hTLR8, respectively[1]. |
| CAS | 1258457-58-7 |
| Formula | C22H25N5 |
| Molar Mass | 359.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kushvinder Kumar, et al. Modulation of the Adjuvant Potential of Imidazoquinoline-Based TLR7/8 Agonists via Alum Adsorption. ACS Med. Chem. Lett. 2024, July. 22. |
m-AM-BBIQ
CAS: 1258457-58-7 F: C22H25N5 W: 359.47
m-AM-BBIQ (compound 10) is a dual TLR7 and TLR8 agonist, with EC50 values of 0.12 μM and 1.7 μM for hTLR7 and hTLR8, r
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.